Latest Intellectual Property News

Livium Ltd and Mineral Resources Ltd have formalised a 50 – 50 joint venture to commercialise the innovative LieNA® lithium processing technology, aiming to license it globally despite current market headwinds.

Provaris Energy has launched a fully funded Front End Engineering Design phase for its proprietary large-scale liquid CO2 tanks, backed by Yinson. The move signals growing market interest in scalable carbon capture shipping solutions, especially across Asia.

Invex Therapeutics reports a significantly reduced net loss for FY25, driven by lower R&D costs after closing its Phase III trial, while advancing promising pre-clinical Alzheimer’s research through a collaboration with Tessara Therapeutics.

Memphasys Limited pivots from development to commercial execution with its flagship IVF product Felix, targeting global markets through direct sales and recurring revenue streams.

Silex Systems Limited has announced a $145 million equity raise to fund the commercialisation of its SILEX laser uranium enrichment technology through its US joint venture, Global Laser Enrichment. The capital will support critical technology milestones and expansion into new isotope markets amid a global nuclear fuel renaissance.

Light & Wonder reported a slight revenue dip in Q2 2025 but expanded earnings and margins, fueled by its $850 million Grover acquisition and a strategic shift to a sole ASX listing.

FBR Limited has locked in a A$20 million share subscription facility with GEM Global Yield LLC, providing flexible capital to advance its innovative robotics platforms and commercialisation efforts.

News Corporation reported a robust fiscal 2025 with revenues climbing 2% to $8.45 billion and net income from continuing operations surging 71%. The company also announced a new $1 billion accelerated stock repurchase program, underscoring confidence in its financial strength.

Zoono Group Limited has closed its recent rights issue, raising $785,000 with a significant shortfall remaining. Managing Director Paul Hyslop fully subscribed and may provide further financial support as the company targets growth in Asia and product innovation.

Vitrafy Life Sciences reported a $32.7 million loss for FY25, driven by investments in its next-generation cryopreservation platform following a $35 million IPO and a $4.8 million government grant. The company is progressing commercialization efforts with key partnerships in human and animal health.

Imagion Biosystems has raised A$3.5 million through a placement to fund its Phase 2 clinical trial for HER2+ Breast Cancer in the US, marking a significant step in advancing its proprietary MagSense® imaging technology.

FBR Limited has secured a significant $7.8 million memorandum of understanding for its Hadrian X® robotic bricklayer and launched a new DST®-enabled welding robot, Mantis, while advancing automation projects with Samsung Heavy Industries.